The Limited Times

Now you can see non-English news...

Vaccine hammer: Biontech reports huge success after study - game changer for children and parents?

2021-03-31T12:58:31.923Z


Germany is discussing the Astrazeneca vaccine, meanwhile Biontech publishes a great success for its corona vaccine. Founder Ugur Sahin names a new goal.


Germany is discussing the Astrazeneca vaccine, meanwhile Biontech publishes a great success for its corona vaccine.

Founder Ugur Sahin names a new goal.

Munich / Marburg - In the coronavirus pandemic in Germany, she is not only the much-cited hope of Federal Health Minister Jens Spahn (CDU): the pharmaceutical company Biontech based in Mainz (Rhineland-Palatinate).

Because: Biontech has developed a corona vaccine.

The only thing is that this is unfortunately not yet available in the Federal Republic in the quantities that Spahn - and many citizens - would like.

So that we can finally find a way out of the seemingly endless Covid 19 crisis.

Biontech vaccine against corona: 100 percent effectiveness in the young age group

“Germany will get enough vaccine”, promised Biontech founder Ugur Sahin just in the days of the Astrazeneca vaccine setback in an interview with the news magazine

Spiegel

(print edition).

And this Wednesday (March 31st) he was able to announce a great success with his company.

Because: According to the company, the corona vaccine from Biontech and Pfizer has shown an effectiveness of one hundred percent in adolescents between twelve and 15 years of age in an approval study.

In addition, the tolerance of the vaccine for children and adolescents of this age is "good", the German-American pharmaceutical cooperation said.

Ugur Sahin from Biontech: Extend vaccinations against Corona to this age group (12 to 15)

The companies spoke of “very high antibody responses” among study participants aged twelve to 15 years.

The goal is now to expand vaccinations against the coronavirus and its mutations "as quickly as possible" to this age group.

"It is very important to enable children to return to normal school life and to meet family and friends," said Sahin.

In the European Union (EU) and in the USA, the vaccine has so far only been approved from the age of 16.

In general, this group of people receives comparatively little attention in the vaccination debate, because it is mainly about corona risk groups - and the vaccination sequence is aligned accordingly.

So now there is a glimmer of hope that affects exactly those young people who are also affected in the third wave in a record-breaking way.

Is this the game changer for children / adolescents and their parents?

Corona vaccine from Germany: In the future, millions of new vaccine doses from Biontech's Marburg plant

Meanwhile, things are evidently progressing with another goal.

In an effort to expand vaccine production in order to fill the considerable gaps in demand (not only in Germany).

Just recently, Biontech put one of the largest vaccine plants into operation in Marburg (Hessen).

According to the

FAZ

, eight million new vaccine doses will come from the tranquil university town every five days.

Well tolerated by fellow citizens between twelve and 15 years of age.

(pm)

Source: merkur

All news articles on 2021-03-31

You may like

Trends 24h

Latest

© Communities 2019 - Privacy

The information on this site is from external sources that are not under our control.
The inclusion of any links does not necessarily imply a recommendation or endorse the views expressed within them.